Trial Profile
A multi-centre, retrospective study to evaluate the real world effect of golimumab in the treatment of Ankylosing Spondylitis (AS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2017
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 17 Oct 2017 New trial record
- 12 Oct 2017 Results presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research